Esheref Haxhiu is a PhD candidate in Psychology at The University of Warsaw, Poland. He has completed his Master’s in Counseling Psychology at Sheffield University. He has completed his Bachelor’s at The University of Pristina. Previously, he has worked as a high school Teacher of Psychology in Kosovo.
Background & Aim: The Difficulties in Emotional Regulation Scale (DERS) is a 36-item self-report scale, designed to assess multiple aspects of emotional dysregulation. These aspects include: an acceptance of emotional responses, difficulties engaging in goals-directed behavior, impulse control difficulties, lack of emotional awareness, limited access to emotion regulation strategies, and the lack of emotional clarity. The DERS is a new and promising scale, and the previous findings suggest that it has good psychometric properties. The purpose of the present study is to make the Albanian population adapt the DERS scale. Methods: Two independent professional translators have translated the scale from the English version into Albanian, and then the back translation was done from another third translator. After completing the translation process, a sample of 340 high school students (n=340), age 18-19, fulfilled the questionnaire twice in a two-week period. Results: The results reveal that the Albanian version of DERS has good psychometric properties. The internal consistency of the scale in both study phases was shown to be high (α ≥0.85), as well the test-retest reliability (r=0.85). Conclusions: The Albanian version of DERS is a reliable scale for measuring the difficulties in emotional regulation for the respective population.
Vijaya Padma Kotapati has completed her Medical School from Meenakshi Medical College in India. After completing her degree she cleared her USMLE with flying colors. She has a keen interest in research and wants to pursue Psychiatry residency and will be applying in the upcoming March. Currently, she is working at Manhattan Psychiatric Center as a Research Intern.
Obsessive-compulsive disorder (OCD) is a common behavioral disorder among adolescents and children. The selective serotonin reuptake inhibitors (SSRI) are the first pharmacological choice for this condition due to mild adverse effect profile. This systematic review was performed to evaluate the efficacy of SSRI for OCD in adolescents and children. Search terms were entered into PubMed, PsycINFO, Scopus, CINAHL and Google Scholar. The included studies were randomized, placebo-controlled trials of SSRIs conducted in populations of children and adolescents younger than 18 years. Change from baseline CY-BOCS, end-treatment CY-BOCS with respective SD and response and remission rates were collected for continuous and dichotomous outcome assessment, respectively. Cochrane RevMan software was used for meta-analyses, providing Forest plots where applicable. SSRIs were superior to placebo with a small effect size. There was no additional benefit of combination treatment over CBT alone, but CBT added substantial benefit to SSRI monotherapy. Fluoxetine and Sertraline appear to be superior to Fluvoxamine. The results of current systematic review and meta-analysis support the existing NICE guidelines for choosing CBT as the first line of treatment and substituting it with SSRI depending on patient preference. Adding CBT to current SSRI treatment is effective for non-responders and partial responders, but adding SSRI to ongoing CBT does not prove beneficial. The SSRIs have different effectiveness and their relative efficacy remains to be investigated.